Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms-Reference-Cited by-同舟云学术

Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms

Published:2021-12-07 Issue:2 Volume:12 Page:11700-11708
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Su Qiang¹²,Liu Qiao³,Liu Juan⁴,Fu Lingyun⁵,Liu Tao²⁶,Liang Jing¹²,Peng Hong⁷,Pan Xue⁸

Affiliation:

1. Department of Pharmacy, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, P.R. China

2. Nanchong Key Laboratory of Individualized Drug Therapy, Nanchong, P.R. China

3. School of Pharmacy, North Sichuan Medical College, Nanchong, P.R. China

4. Department of Pediatrics, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, P.R. China

5. Department of Health Management Center, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, P.R. China

6. Department of Cardiology, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, P.R. China

7. Department of Anorectal Surgery, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, P.R. China

8. Scientific Research Department, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China

Funder

Scientific Research Projects on Basic Scientific and Technological Strategic Cooperation of Nanchong Municipal Schools

Scientific Research Projects of Sichuan Education Department

Sichuan Grass-roots Health Development Research Center Project

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2003930

Reference36 articles.

1. WHO global progress report on tuberculosis elimination

2. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

3. Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis

4. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury;International Immunopharmacology;2024-09

2. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury;Drug Metabolism and Disposition;2024-04-26

3. Ferroptosis: action and mechanism of chemical/drug-induced liver injury;Drug and Chemical Toxicology;2023-12-26

4. Pharmacokinetic assessment of rifampicin and des-acetyl rifampicin in carbon tetrachloride induced liver injury model in Wistar rats;Journal of Complementary and Integrative Medicine;2023-12-25

5. Regulation of Gut Microflora by Lactobacillus casei Zhang Attenuates Liver Injury in Mice Caused by Anti-Tuberculosis Drugs;International Journal of Molecular Sciences;2023-05-29